Gelteq Limited (GELS) vs China SXT Pharmaceuticals, Inc. (SXTC)

Gelteq Limited and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Gelteq Limited is the larger, with a market value of $5.9M against $3.5M — 1.7× the size. Across the 4 metrics below, China SXT Pharmaceuticals, Inc. leads on 3 and Gelteq Limited on 1.

Valuation

Metric GELS SXTC Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S — n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 2.66 12.29
EV/Sales n/m (5.94) 2.56
Earnings yield — (4,331.13%) (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric GELS SXTC Drug Manufacturers Specialty & Generic median
Gross margin — 36.69% 53.94%
Operating margin — 0.00% 0.00%
Net margin — (255.16%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GELS SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (53.98%) 10.01%
EPS growth (last fiscal year) (62.07%) 97.36% —
Revenue growth, 5-year CAGR — (24.94%) 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS SXTC Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.03 0.05
Current ratio 0.09 7.94 2.31
Net debt to EBITDA (0.91) 3.86 0.85

Dividend

Metric GELS SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric GELS SXTC Drug Manufacturers Specialty & Generic median
Market cap 5.89m 3.49m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack